FI953878A0 - Förfarande för att förhindra och inhibera befruktning - Google Patents

Förfarande för att förhindra och inhibera befruktning

Info

Publication number
FI953878A0
FI953878A0 FI953878A FI953878A FI953878A0 FI 953878 A0 FI953878 A0 FI 953878A0 FI 953878 A FI953878 A FI 953878A FI 953878 A FI953878 A FI 953878A FI 953878 A0 FI953878 A0 FI 953878A0
Authority
FI
Finland
Prior art keywords
preventing
procedure
inhibiting fertilization
fertilization
inhibiting
Prior art date
Application number
FI953878A
Other languages
English (en)
Finnish (fi)
Other versions
FI953878A (sv
FI114687B (sv
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of FI953878A0 publication Critical patent/FI953878A0/sv
Publication of FI953878A publication Critical patent/FI953878A/sv
Application granted granted Critical
Publication of FI114687B publication Critical patent/FI114687B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fertilizers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FI953878A 1993-02-19 1995-08-17 Kit för att förhindra befruktning FI114687B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1979193 1993-02-19
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
US9401804 1994-02-18
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (3)

Publication Number Publication Date
FI953878A0 true FI953878A0 (sv) 1995-08-17
FI953878A FI953878A (sv) 1995-08-17
FI114687B FI114687B (sv) 2004-12-15

Family

ID=21795040

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953878A FI114687B (sv) 1993-02-19 1995-08-17 Kit för att förhindra befruktning

Country Status (24)

Country Link
US (1) US5516769A (sv)
EP (2) EP1159965B1 (sv)
JP (1) JP3054780B2 (sv)
KR (1) KR100232833B1 (sv)
AT (2) ATE218347T1 (sv)
AU (1) AU692150B2 (sv)
BG (1) BG62431B1 (sv)
BR (1) BR9406666A (sv)
CA (1) CA2156493C (sv)
CZ (1) CZ294325B6 (sv)
DE (2) DE69430732T2 (sv)
DK (2) DK0684825T3 (sv)
ES (1) ES2231356T3 (sv)
FI (1) FI114687B (sv)
HU (1) HU221162B1 (sv)
NO (1) NO307916B1 (sv)
NZ (1) NZ262998A (sv)
PL (1) PL175440B1 (sv)
PT (2) PT1159965E (sv)
RO (1) RO118565B1 (sv)
RU (1) RU2139055C1 (sv)
SK (1) SK282068B6 (sv)
UA (1) UA41351C2 (sv)
WO (1) WO1994018982A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
AU781835B2 (en) 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
WO1994018982A1 (en) 1994-09-01
BR9406666A (pt) 1996-01-23
EP1159965A2 (en) 2001-12-05
DE69430732T2 (de) 2002-10-24
HU221162B1 (en) 2002-08-28
DK1159965T3 (da) 2005-05-23
EP1159965B1 (en) 2005-01-12
AU692150B2 (en) 1998-06-04
SK282068B6 (sk) 2001-10-08
BG62431B1 (bg) 1999-11-30
DE69430732D1 (de) 2002-07-11
US5516769A (en) 1996-05-14
BG99867A (bg) 1996-04-30
KR100232833B1 (ko) 1999-12-01
RU2139055C1 (ru) 1999-10-10
CZ205095A3 (en) 1996-01-17
ATE218347T1 (de) 2002-06-15
CA2156493C (en) 2002-10-29
SK101395A3 (en) 1997-04-09
RO118565B1 (ro) 2003-07-30
ES2231356T3 (es) 2005-05-16
NZ262998A (en) 1997-06-24
JP3054780B2 (ja) 2000-06-19
DK0684825T3 (da) 2002-07-15
PL175440B1 (pl) 1998-12-31
PT1159965E (pt) 2005-03-31
EP0684825B1 (en) 2002-06-05
KR960700726A (ko) 1996-02-24
NO307916B1 (no) 2000-06-19
NO953242D0 (no) 1995-08-17
EP0684825A1 (en) 1995-12-06
EP1159965A3 (en) 2002-05-22
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
HUT72079A (en) 1996-03-28
FI953878A (sv) 1995-08-17
EP0684825A4 (en) 1998-01-14
ATE286734T1 (de) 2005-01-15
CA2156493A1 (en) 1994-09-01
JPH08510992A (ja) 1996-11-19
PL310357A1 (en) 1995-12-11
PT684825E (pt) 2002-10-31
NO953242L (no) 1995-08-17
CZ294325B6 (cs) 2004-11-10
UA41351C2 (uk) 2001-09-17
FI114687B (sv) 2004-12-15
AU6299294A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
FR2656521B1 (fr) Procede et dispositif pour melanger et administrer directement au point d'application un ciment osseux constitue de deux composes.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
FR2784296B1 (fr) Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
FI941396A0 (sv) Kompositioner för kontrollerad frigöring av biologiskt aktivt TGF
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
ES2132339T3 (es) Derivados sulfonato y carbamato de los 3-aroilbenzo(beta)tiofenos.
ES2114605T3 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
CY2121B1 (en) Derivatives of amidinophenylalanine procedure for their preparation their utilisation and compositions comprising them
ES8707733A1 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
DE69113379D1 (de) 3-Aryl-4(3H)chinazolinone als CCK Antagonisten und diese enthaltende pharmazeutische Zusammensetzungen.
FI953878A (sv) Förfarande för att förhindra och inhibera befruktning
ES8205759A1 (es) Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos.
EP0467365A3 (en) Use of a 5-hydroxytryptamine-3(5-ht3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
ES2091570T3 (es) Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
JPS548722A (en) Fungicides for agriculture and horticultre
MX9301546A (es) Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado
MX9710377A (es) Compuestos con propiedades de liberacion de la hormona de crecimiento.

Legal Events

Date Code Title Description
MA Patent expired